Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas.
Berrino E, Annaratone L, Bellomo SE, Ferrero G, Gagliardi A, Bragoni A, Grassini D, Guarrera S, Parlato C, Casorzo L, Panero M, Sarotto I, Giordano S, Cereda M, Montemurro F, Ponzone R, Crosetto N, Naccarati A, Sapino A, Marchiò C.
Berrino E, et al. Among authors: bragoni a.
Genome Med. 2022 Aug 29;14(1):98. doi: 10.1186/s13073-022-01104-z.
Genome Med. 2022.
PMID: 36038884
Free PMC article.